Voltammetric Determination of Ethionamide in Pharmaceutical Formulations and Human Urine using a Boron-Doped Diamond Electrode
At a Glance
Section titled “At a Glance”| Metadata | Details |
|---|---|
| Publication Date | 2015-01-01 |
| Journal | Journal of the Brazilian Chemical Society |
| Authors | Bruno Regis Lyrio Ferraz, Fernando Roberto Figueirêdo Leite, Bruna Lima Farias Batista, Andréa R. Malagutti |
| Institutions | Universidade Federal dos Vales do Jequitinhonha e Mucuri |
| Citations | 20 |
| Analysis | Full AI Review Included |
Executive Summary
Section titled “Executive Summary”- Breakthrough Application: First successful deployment of a Boron-Doped Diamond Electrode (BDDE) for the electrochemical quantification of the tuberculosis antibiotic Ethionamide (ETO) in both pharmaceutical formulations and human urine.
- Material Utilization: The study leveraged a thin-film BDDE (1.2 µm boron-doped diamond on a polycrystalline silicon substrate, 8000 ppm boron) to achieve high sensitivity, stability, and resistance to passivation.
- Performance Metrics: Achieved a wide linear detection range of 1.00 to 80.0 µmol L−1 with a Limit of Detection (LOD) of 0.294 µmol L−1, outperforming several traditional spectrophotometric and HPLC methods.
- Operational Robustness: Demonstrated excellent selectivity against common interferents (ascorbic acid, uric acid, starch, microcrystalline cellulose, magnesium stearate, citric acid) with a relative standard deviation (RSD) generally < 5%.
- Validation: Method accuracy confirmed via standard addition with recovery rates between 100.8% and 105.1% in real-world matrices (urine and tablets).
- Technique: Square Wave Voltammetry (SWV) on a cathodically treated BDDE in a Britton-Robinson buffer solution (pH 5.0) to track the cathodic reduction of ETO.
Technical Specifications
Section titled “Technical Specifications”| Parameter | Value | Unit | Context |
|---|---|---|---|
| Electrode Material | Boron-Doped Diamond (BDD) | - | Thin film deposited on polycrystalline silicon |
| Film Thickness | ~1.2 | µm | Thin-film diamond active layer |
| Boron Content | ~8000 | ppm | Heavy doping for metallic-like conductivity |
| Exposed Electrode Area | 0.35 | cm2 | Geometric surface area of working electrode |
| Reference Electrode | Ag/AgCl (3 mol L−1 KCl) | - | Standard reference for potential measurements |
| Counter Electrode | Platinum foil (1.0 cm2) | - | Auxiliary electrode |
| Support Electrolyte | Britton-Robinson Buffer Solution (BRBS) | - | 0.1 mol L−1 at pH 5.0 |
| Target Analyte | Ethionamide (ETO) | - | Tuberculosis antibiotic |
| Linear Range | 1.00 - 80.0 | µmol L−1 | Calibration range in buffer |
| Limit of Detection (LOD) | 0.294 | µmol L−1 | Calculated via 3σ/b (IUPAC) |
| Limit of Quantification (LOQ) | 0.981 | µmol L−1 | Calculated via 10σ/b |
| SWV Amplitude (a) | 60 | mV | Optimized pulse amplitude |
| SWV Step Potential (ΔEs) | 1 | mV | Optimized potential step |
| SWV Frequency (f) | 50 | s−1 | Optimized frequency |
| Scan Rate (CV) | 10 - 150 | mV s−1 | Range evaluated for mechanism studies |
| Intra-day Precision (RSD) | 2.30 - 3.30 | % | Measured at 40, 60, 70 µmol L−1 |
| Inter-day Precision (RSD) | 3.50 - 4.80 | % | Measured over 7 days |
| Recovery Rate | 100.8 - 105.1 | % | Standard addition in real matrices |
| Analytical Frequency | ~10 | determinations/hour | Sample throughput |
| Working Temperature | Room Temperature (~25) | °C | Ambient lab conditions |
| Pre-treatment | Cathodic activation in H2SO4 | - | +3.0 V (15 s), −3.0 V (45 s) in 0.5 mol L−1 H2SO4 |
Key Methodologies
Section titled “Key Methodologies”- Electrode Preparation: The BDDE was cathodically treated in 0.5 mol L−1 H2SO4 by applying +3.0 V for 15 seconds followed by −3.0 V for 45 seconds to activate the surface and remove contaminants.
- Electrochemical Cell Setup: Three-electrode configuration utilizing the BDDE as the working electrode, Ag/AgCl (3 mol L−1 KCl) as the reference, and a Pt foil counter electrode.
- Buffer Preparation: 0.1 mol L−1 Britton-Robinson Buffer Solution (BRBS) composed of equimolar phosphoric, acetic, and boric acids, adjusted to pH 5.0 with 1.0 mol L−1 NaOH.
- Mechanism Investigation (CV): Cyclic Voltammetry (CV) scans performed at 100 mV s−1 over a potential range of +1.6 V to −1.4 V to characterize the reduction of the thioamide group (4 electrons, 4 protons).
- Parameter Optimization (SWV): Square Wave Voltammetry parameters optimized to maximize peak current: amplitude (a) = 60 mV, step potential (ΔEs) = 1 mV, and frequency (f) = 50 s−1.
- Calibration & Linearity: Calibration curves constructed across 1.0 to 80.0 µmol L−1 ETO concentrations, prepared and measured over three independent days.
- Real Sample Analysis:
- Tablets: Ground, dissolved in 10% ethanol, filtered, and diluted in BRBS pH 5.0; quantified via standard addition method.
- Urine: Fortified with ETO standard, diluted in BRBS pH 5.0; quantified via standard addition method.
- Interference Testing: Solutions of common interferents tested at a 1:100 (ETO:interferent) concentration ratio to confirm method selectivity.
6CCVD Solutions & Capabilities
Section titled “6CCVD Solutions & Capabilities”The experimental protocol detailed in this paper demonstrates the critical importance of electrode surface quality, doping homogeneity, and trace-level detection capabilities—all areas where high-purity CVD diamond excels.
- Applicable Materials:
- For researchers aiming to replicate or extend this electroanalytical work, 6CCVD’s Heavy Boron-Doped PCD (BDD) or Boron-Doped Single Crystal Diamond (SCD) provides the ideal foundation. The 8000 ppm boron concentration cited in the paper aligns perfectly with metallic-grade BDD that 6CCVD can engineer. Furthermore, 6CCVD’s PCD can be grown on custom substrates, mimicking the polycrystalline silicon architecture used by the authors, while SCD options provide the ultimate surface smoothness (Ra < 1 nm) for ultra-sensitive, low-noise voltammetry.
- Customization Potential:
- The paper utilizes a specific exposed area (0.35 cm2) and thin-film geometry. We offer fully custom diamond dimensions—plates and wafers up to 125 mm for PCD—coupled with thickness control from 0.1 µm to 500 µm. To facilitate immediate integration into electrochemical cells or printed circuit boards, 6CCVD provides custom metalization (Ti, Pt, Au, Pd, W, Cu) applied via internal sputtering processes, alongside precision laser cutting to achieve the exact exposed window geometries required for your specific reference and counter electrode setups.
- Engineering Support:
- Selecting the appropriate diamond morphology (SCD vs. PCD) and boron doping gradient is crucial for optimizing the electrochemical window, reducing residual current, and preventing passivation in pharmaceutical detection projects. Our in-house PhD engineering team specializes in material consultation for electroanalytical, biosensing, and advanced electrochemical applications. We can guide you on matching the optimal diamond grade to your target analyte to maximize sensitivity and lower your limit of detection.
- Call to Action:
- For custom specifications, material consultation, or a quote on tailored boron-doped diamond electrodes, visit 6ccvd.com or contact our engineering team directly. We ship globally (DDU or DDP) to support your research timeline.
View Original Abstract
This work reports a simple and low cost voltammetric approach comprising a boron-doped diamond electrode (BDDE) to determine the antibiotic ethionamide (ETO). Cyclic voltammetry studies revealed that ETO exhibits an irreversible reduction peak at -0.95 V and an irreversible oxidation peak at +1.4 V onto BDDE (vs. saturated Ag/AgCl reference electrode) in Britton-Robinson buffer solution (pH 5.0, 0.1 mol L-1). Different voltammetric scan rates (from 10 to 150 mV s-1) suggested that the reduction of ETO on the BDDE surface is a diffusion-controlled process. Square wave voltammetry (SWV) optimized conditions showed a linear response to ETO from 1.00 to 80.0 µmol L-1 (R2 = 0.998) with a limit of detection of 0.294 µmol L-1 and limit of quantification of 0.980 µmol L-1. The developed square wave voltammetric method was successfully used in the determination of ETO in human urine and pharmaceutical formulation. The ETO quantification results in pharmaceutical tablets obtained by SWV-BDDE were comparable to those found by official analytical protocols.